Petmed Express (PQM) Stock Statistics & Valuation Metrics
Total Valuation
Petmed Express has a market cap or net worth of EUR 23.12M. The enterprise value is EUR 28.97M.
- Market Cap
- EUR 23.12M
- Enterprise Value
- EUR 28.97M
Share Statistics
Petmed Express has 21,678,913 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 21,678,913
- Owned by Insiders
- 16.56%
- Owned by Institutions
- 12.91%
Financial Efficiency
Petmed Express’s return on equity (ROE) is -1.98 and return on invested capital (ROIC) is -105.82%.
- Return on Equity (ROE)
- -1.98
- Return on Assets (ROA)
- -0.71
- Return on Invested Capital (ROIC)
- -105.82%
- Return on Capital Employed (ROCE)
- -1.08
- Revenue Per Employee
- 947.20K
- Profits Per Employee
- -303.10K
- Employee Count
- 189
- Asset Turnover
- 2.20
- Inventory Turnover
- 10.16
Valuation Ratios
The current PE Ratio of Petmed Express is -0.90. Petmed Express’s PEG ratio is -0.21.
- PE Ratio
- -0.90
- PS Ratio
- 0.16
- PB Ratio
- 1.17
- Price to FCF
- -0.97
- Price to Operating Cash Flow
- -1.13
- PEG Ratio
- -0.21
Income Statement
In the last 12 months, Petmed Express had revenue of 179.02M and earned -57.29M in profits. Earnings per share was -2.74.
- Revenue
- 179.02M
- Gross Profit
- 40.83M
- Operating Income
- -31.41M
- Pretax Income
- -57.36M
- Net Income
- -57.29M
- EBITDA
- -22.03M
- Earnings Per Share (EPS)
- -2.74
Cash Flow
In the last 12 months, operating cash flow was -23.81M and capital expenditures -3.96M, giving a free cash flow of -27.77M billion.
- Operating Cash Flow
- -23.81M
- Free Cash Flow
- -27.77M
- Free Cash Flow per Share
- -1.28
Dividends & Yields
Petmed Express pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -104.01%
- Earnings Yield
- -109.62%
Stock Price Statistics
- Beta
- 1.50
- 52-Week Price Change
- -47.89%
- 50-Day Moving Average
- 1.24
- 200-Day Moving Average
- 1.71
- Relative Strength Index (RSI)
- 45.26
- Average Volume (3m)
- 1,092
Important Dates
Petmed Express upcoming earnings date is Nov 10, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 10, 2026
- Ex-Dividend Date
- ―
Financial Position
Petmed Express as a current ratio of 0.84, with Debt / Equity ratio of 1.85%
- Current Ratio
- 0.84
- Quick Ratio
- 0.58
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.95
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Petmed Express has paid -73.00K in taxes.
- Income Tax
- -73.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Petmed Express EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.51.
- EV to Sales
- 0.08
- EV to EBITDA
- -0.65
- EV to Free Cash Flow
- -0.51
- EV to Operating Cash Flow
- -0.59
Balance Sheet
Petmed Express has EUR 13.08M in cash and marketable securities with EUR 414.00K in debt, giving a net cash position of EUR 12.66M billion.
- Cash & Marketable Securities
- EUR 13.08M
- Total Debt
- EUR 414.00K
- Net Cash
- EUR 12.66M
- Net Cash Per Share
- EUR 0.58
- Tangible Book Value Per Share
- EUR 0.82
Margins
Gross margin is 23.71%, with operating margin of -18.22%, and net profit margin of -17.34%.
- Gross Margin
- 23.71%
- Operating Margin
- -18.22%
- Pretax Margin
- -17.38%
- Net Profit Margin
- -17.34%
- EBITDA Margin
- -12.89%
- EBIT Margin
- -18.37%
Analyst Forecast
The average price target for Petmed Express is EUR 1.25, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
- Price Target
- EUR 1.25
- Price Target Upside
- 20.10% Upside
- Analyst Consensus
- Moderate Sell
- Analyst Count
- 1
- Revenue Growth Forecast
- -25.07%
- EPS Growth Forecast
- 37.94%
